Published on Tuesday, August 18, 2026 by Staff
Johnson & Johnson announced a proposed $5.5 billion settlement on July 27, 2026. The deal could resolve about 76,000 lawsuits that claim its talc products caused ovarian cancer. It could end nearly all current ovarian cancer claims against the company in federal and state courts. However, the Johnson & Johnson talc settlement is not final.
At least 95% of the remaining claimants must agree to take part. The proposal covers current ovarian cancer claims, not future lawsuits. It also does not cover the remaining claims that link asbestos in talc to mesothelioma.
Johnson & Johnson negotiated the proposed settlement with the law firms leading the federal cases. These cases are grouped in New Jersey as multidistrict litigation, also called an “MDL.” Lawyers handling related cases in state courts also took part in the talks.
The main terms of the settlement include:
The terms of the proposal do not utilize a fixed fund divided among all claimants. Instead, the agreement sets values for qualifying claims. Lead plaintiffs' lawyer Christopher Seeger said Johnson & Johnson could pay $7 billion or more. The final total would depend on the number and value of eligible claims.
The public reports do not say how much each person would receive. Payment may depend on the settlement rules, medical records, and facts of the claim. A claimant should ask their lawyer for advice before deciding whether to join the deal.
The settlement is not final, as several conditions must be met before it can take effect. One key condition is that at least 95% of the remaining claimants must agree to take part. Until then, the proposal is not a completed settlement.
Johnson & Johnson did not admit fault. The company still denies that its talc products caused cancer. However, they agreed to the deal to end the lawsuits.
The proposal follows three failed efforts to resolve talc claims through bankruptcy. In April 2025, a bankruptcy judge rejected a plan worth about $9 billion. Johnson & Johnson did not appeal. The company then returned to the civil court process.
The deal is meant for current claims that link Johnson & Johnson talc products to ovarian cancer. It covers claims in the federal MDL and related state cases.
The announcement does not mean that every person who used Johnson's Baby Powder or another talc product will qualify. Public reports do not give a full list of eligibility rules or payment amounts at this time.
People with pending claims should talk to the lawyers handling their cases. Their lawyers can explain the deadlines, the terms, and what it would mean to accept an offer. In most settlements, a person who accepts payment must give up the covered legal claims.
The proposed settlement leaves many questions to be answered. Eligibility, deadlines, and possible payment will depend on each person's claim. If you have questions about your filed talc claim, we encourage you to contact your attorney promptly so he/she can provide you with answers.